Clinical Trial

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2016-05-27; most recent amendment 2025-09-12.
Status change: Recruiting → Active, Not Recruiting 2022-06-03
Trial Details
NCT Number NCT02785848
Lead Sponsor Vanderbilt University
Conditions Sickle Cell Disease
Enrollment 70 participants
Start Date 2016-05
Primary Completion 2022-05 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-16